Board Member, RAIN Incubator and Recombinetics
Marylinn Munson has worked in the life science, biotechnology and agriculture industries for more than 20 years. Currently she is on two Boards, RAIN Incubator advancing STEM and Recombinetics solving intractable challenges through gene editing. She has held international leadership roles at industry-leading biotech and life science companies. At Neogen she led the Genomics business; she managed the international genomics informatics field team at Qiagen; built and managed a field sales team and an international operations group where she was responsible for 60 percent of Illumina’s global business; and part of a Core Strategy Team, business development and marketing at Agilent. At Amersham Biosciences (GE Healthcare), she sold Next Generation Systems in North America, many of which were used as part of the Human Genome Project. Marylinn’s passion for excellence, people and customers has made her the recipient of industry awards including the Federal Labs Consortium Award for Technology Transfer. She is listed as an inventor on U.S. patents.